drugset / Trial / NCT00115778

Intravenous Immunoglobulin (IVIG) in Lung Transplantation

NCT00115778

RandomizedCrossoverQuadruple-blindPrevention

Summary

The purpose of this study is to determine if intravenous immunoglobulin (IVIG) can prevent bacterial infections in lung transplant patients with low serum levels of immunoglobulin.

Timeline

Start
2005-06
Primary completion
2009-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic 400 mg/kg Intravenous

Indications